Strategic Enterprise AI Security Leader

Eli Lilly and Company; Indianapolis (IN); On-site; USD 129,000 - 253,000; Full time

Benefits offered by this job

Company bonus

401(k) plan

Health benefits

Well-being benefits

Job summary

Eli Lilly and Company seeks an Enterprise AI Security Advisor to lead secure adoption of AI across the organization. You will own the strategy, requirements, and roadmaps for AI security, collaborating with engineering, platform, and security operations teams to implement controls.

This senior role demands deep cybersecurity expertise, threat modeling, and hands-on leadership to guide AI safety, governance, and risk management in a regulated pharmaceutical environment.

Qualifications

• Bachelor’s degree in Computer Science, Cybersecurity, Information Systems, or a related IT technical field.
• 10+ years of experience in cybersecurity, security architecture, or platform/software engineering.
• Experience in technical leadership, architecture, or senior advisory capacity.

Responsibilities

• Define AI security strategy and roadmap across the enterprise.
• Define security requirements and reference architectures for AI systems.
• Assess AI systems and vendors to determine risk and needed controls.
• Mentor engineers and security operations on AI threat models and safe patterns.

Skills

Cybersecurity leadership

Security architecture

AI security

Threat modeling

Education

Bachelor’s degree in Computer Science, Cybersecurity, Information Systems, or a related IT technical field

Tools

SIEM/SOAR

EDR

Cloud platforms (AWS/Azure)

Job description

Eli Lilly and Company seeks an Enterprise AI Security Advisor to lead secure adoption of AI across the organization. You will own the strategy, requirements, and roadmaps for AI security, collaborating with engineering, platform, and security operations teams to implement controls.

This senior role demands deep cybersecurity expertise, threat modeling, and hands-on leadership to guide AI safety, governance, and risk management in a regulated pharmaceutical environment.